Insider Trading & Ownership of Enavate Sciences GP, LLC

Location
New York, NY
Summary
The estimated value of insider holdings of Enavate Sciences GP, LLC is at least $63,943,103 dollars as of 17 Oct 2024. Enavate Sciences GP, LLC is the 10%+ Owner of Zenas BioPharma, Inc. and owns shares of Zenas BioPharma, Inc. (ZBIO) stock worth about $63.94M.
Signature
Enavate Sciences GP, LLC, By: /s/ James P. Boylan, Manager
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Enavate Sciences GP, LLC and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Enavate Sciences GP, LLC has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $63,943,103.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Zenas BioPharma, Inc. ($63,943,103).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Enavate Sciences GP, LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ZBIO Zenas BioPharma, Inc. 10%+ Owner $63,943,103 16 Sep 2024
CAMP Camp4 Therapeutics Corp 10%+ Owner 15 Oct 2024

Insider Transactions Reported by Enavate Sciences GP, LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored